OncoCare
Human Papillomavirus(HPV), a common sexually transmitted infection, is now understood to play a major role in causing head and neck cancers, alongside its well-known connection with cervical cancer. Although the connection between HPV and cervical cancer is widely recognised, there has been growing interest in the relationship between HPV and head and neck cancer in recent times.
HPV infection is very common, affecting the majority of men and women who have been sexually active. Regardless of whether someone has had multiple sexual partners or just one, the risk of contracting at least one type of genital HPV remains. This risk persists even for individuals who delay sexual activity until marriage or maintain monogamous relationships, as they can still be exposed to HPV if their partner has been infected.
Transmission of HPV primarily occurs through skin-to-skin contact during sexual activities, including vaginal, anal, and oral sex. Notably, the virus can be transmitted even when the infected individual shows no visible signs or symptoms. While less common, HPV can also be spread through genital contact without intercourse.
Every year, Singapore sees a minimum of 800 new cases of head and neck cancer. Globally, the prevalence of this cancer category is on the rise, potentially due to the increased risk of human Papillomavirus(HPV) infection, specifically linked to oropharyngeal cancer, a subtype of head and neck cancer.
Oropharyngeal cancer develops in the oropharynx, the middle part of the throat. HPV can infect the mouth and throat, causing cancers in the oropharynx, including the back of the throat, the base of the tongue, and the tonsils, leading to oropharyngeal cancer.
Symptoms of Oropharyngeal cancer:
Risk Factors of Oropharyngeal Cancer:
You can take proactive measures to minimise your risk.
Here are some steps you can take:
The HPV vaccine was developed to prevent cervical and other cancers of the reproductive system. The vaccine protects against the types of HPV that can cause oropharyngeal cancers, so it may also prevent oropharyngeal cancers.
Vaccination is not recommended for everyone older than age 26 years. However, some adults aged 27 through 45 years who are not already vaccinated may decide to get the HPV vaccine after speaking with their doctor about their risk for new HPV infections and the possible benefits of vaccination. HPV vaccination in this age range provides less benefit, as more people have already been exposed to HPV.
HPV vaccination prevents new HPV infections but does not treat existing infections or diseases. This is why the HPV vaccine works best when given before any exposure to HPV.
In conclusion, the connection between HPV infection and oropharyngeal cancer underscores the importance of preventive measures and early detection. By promoting HPV vaccination, adopting healthy lifestyle choices, and maintaining regular medical check-ups, individuals can significantly reduce their risk of developing oropharyngeal cancer. Additionally, ongoing research and public awareness efforts are vital in advancing our understanding of HPV-related cancers and enhancing preventive strategies to safeguard public health.
Always prioritise your health, and if you experience any symptoms, don't hesitate to consult our specialists in head and neck cancers. You can schedule an appointment with our esteemed specialists, Dr Tan Chee Seng or Dr Leong Swan Swan, for expert guidance and personalised care.
“Expert knowledge means better care for cancer”
Contributed by:
MBBS (Singapore)
MRCP (United Kingdom)
Site Map | PDPA | Terms of Use | Disclaimer |
Contact Us | Career | Media Contact